Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||
| Net Income | -22,660 | -57,025 |
| Depreciation Amortization | 998 | 1,979 |
| Other Working Capital | -363 | -1,705 |
| Other Operating Activity | 7,844 | 10,642 |
| Operating Cash Flow | $-14,181 | $-46,109 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -63 | -1,222 |
| Other Investing Activity | -29 | -412 |
| Investing Cash Flow | $-91 | $-1,634 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 4,849 | 46,468 |
| Financing Cash Flow | $4,849 | $46,468 |
| Exchange Rate Effect | 60 | 33 |
| Beginning Cash Position | 38,642 | 40,547 |
| End Cash Position | 29,278 | 39,305 |
| Net Cash Flow | $-9,365 | $-1,242 |
| Free Cash Flow | ||
| Operating Cash Flow | -14,181 | -46,109 |
| Free Cash Flow | -14,181 | -46,109 |